New Study Suggests FebriDx® as a ‘Front Door Triage Tool’ in the Fight Against COVID-19

A new study in the Journal of Infection by Dr. Tristan Clark, et al. titled “Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19” identifies the FebriDx® test as a rapid, highly accurate, and affordable ‘front door triage tool’ to help healthcare providers differentiate viral from bacterial infection in patients with suspected COVID-19. In this study of 251 patients, FebriDx showed high diagnostic accuracy and speed for identifying a viral infection when compared to PCR for confirming COVID-19.

SEE ALSO
November 18, 2020

Lumos Diagnostics Partners with WHO and CDC for Antibiotic Awareness Week from November 18-24

From November 18-24, Lumos Diagnostics and partners of WHO’s World Antimicrobial Awareness Week and CDC’s Antibiotic Awareness Week will share what clinicians and patients need to know about antibiotics and the importance of using antibiotics wisely in both community and healthcare settings.

Reach out to Lumos today to understand how we can deliver you a customized point-of-care diagnostic solution.